Neptune and Enzymotec Conclude Final Patent Infringement Settlement and License Agreement

Neptune and Enzymotec Conclude Final Patent Infringement Settlement and License Agreement

[GlobeNewswire] – LAVAL, Quebec — Neptune Technologies & Bioressources Inc. (Neptune) and Acasti Pharma Inc. (Acasti) , a Neptune subsidiary, announce that a final and binding patent infringement … more

View todays social media effects on ACST

View the latest stocks trending across Twitter. Click to view dashboard

See who Acasti is hiring next, click here to view

Share this post